All issues
Volume 74, Issue 11
Displaying 1-5 of 5 articles from this issue
- |<
- <
- 1
- >
- >|
-
Kunihiko ITO, Mitsuyoshi TAKAHASHI, Takashi YOSHIYAMA, Masako WADA, To ...1999 Volume 74 Issue 11 Pages 777-788
Published: November 15, 1999
Released on J-STAGE: May 24, 2011
JOURNAL FREE ACCESSFor many years, it has been thought that positive culture of M. tuberculosis is a definitive diagnostic evidence of tuberculosis and cross-contamination of M. tuberculosis culture in clinical laboratories is rare. However recently introduced RFLP analysis has enabled us to identify a strain of M. tuberculosis, and many cases of the cross-contamination in clinical laboratories confirmed by RFLP analysis have been reported.
In this report, we present the first case of the cross-contamination confirmed by RFLP in Japan. In our case, 5 patients without any personal link to each other were suspected based on clinical findings to have cross-contaminated results of M. tuberculosis culture. All their specimens were processed on the same day, and were smear negative and culture positive with only a small number of colonies (less than 8 colonies). The sputum from the suspected source of contamination processed on the same day was strongly positive for AFB smear and heavily culture positive. The RFLP patterns of these 6 patients were identical, so it was concluded that the positive cultures of the sputum from the 5 patients who were not expected to be culture positive on clinical findings were caused by the cross-contamination in our hospital laboratory. We review all the charts of patients with M. tuberculosis culture positive results in the same year of this case, but we didn't find no other cases suspected of the cross-contamination.
Then we reviewed the literature of M. tuberculosis culture cross-contamination. The patterns of the cross-contamination are divided into two. One is associated with malfunction of a sampling needle in the BACTEC 460 system and the other associated with the initial processing of the specimens, mostly involving reagents such as NaOH solution.Cross-contaminated specimens are usually smear negative with only a few colonies (less than 5), and processed just after the source specimen of the contamination in most reported cases, but not in all. In almost half of them the cross-contamination results had significant influence on the clinical management. The frequency of the cross-contamination is estimated around 1% of the patients with M. tuberculosis culture positive results.
For early detection of the cross- contamination, not only clinicians but also laboratory staffs have important role and close cooperation between them is mandatory. To prevent the contamination, it is advisable to process smear positive and probable culture positive specimens separately from others, and not to use a large same container of reagents for processing of different specimens.View full abstractDownload PDF (3172K) -
Yoshihiro KOBASHI, Hirohide YONEYAMA, Niro OKIMOTO, Toshiharu MATSUSHI ...1999 Volume 74 Issue 11 Pages 789-795
Published: November 15, 1999
Released on J-STAGE: May 24, 2011
JOURNAL FREE ACCESSIn the last five years, five patients (three males and two females) among a total of 162 patients (3.1%) ranging from 63 to 79 years old developed pulmonary tuberculosis during the long-term corticosteroid therapy. The underlying diseases of these cases were pulmonary fibrosis in two, polyarteritis nodosa in one, RPGN+pulmonary bleeding in one, and mycosis fungoides in one. The total corticosteroid dose used until the clinical diagnosis of pulmonary tuberculosis was 1.16g to 5.60g and the term of administration was two to nine and a half months.
Other immunosuppressive drugs were administered to two patients. Though chemoprophylaxis with INH was done in two patients for three months, it was impossible to prevent the development of pulmonary tuberculosis. Since almost all patients except one complained no symptoms at the onset, the follow-up with chest roentgenograms seemed to be most important during corticosteroid therapy, and in fact, four patients were detected by the follow-up. Antituberculous chemotherapy was effective in four patients but was not carried out for one patient due to the delay in the diagnosis.
Careful clinical observation, such as by chest roentgenograms, seems to be appropriate for the early diagnosis and treatment of pulmonary tuberculosis in patients on orticosteroid therapy.View full abstractDownload PDF (743K) -
Atsuhisa TAMURA, Akira HEBISAWA, Go TANAKA, Hideo TATSUTA, Tomomasa TS ...1999 Volume 74 Issue 11 Pages 797-802
Published: November 15, 1999
Released on J-STAGE: May 24, 2011
JOURNAL FREE ACCESSTo clarify the features of the coexistence of active pulmonary tuberculosis in patients with lung cancer, we analyzed clinical data on 25 cases with coexisting lung cancer and active pulmonary tuberculosis encountered at Tokyo National Chest Hospital during the period from 1991 to 1998. There were 23 men and 2 women, with a mean age of 70 years. The incidence of lung cancer among patients with active pulmonary tuberculosis at our hospital was 0.7 per cent, while the incidence of active pulmonary tuberculosis in untreated lung cancer patients at our hospital was 1.9 per cent. We classified the 25 cases into 2 groups as follows:(1) tuberculosis sequential to lung cancer (11 cases) and (2) tuberculosis concurrently detected with lung cancer (14 cases). All patients in the former group were transferred from other hospitals after diagnosing the coexistence of pulmonary tuberculosis during the management of lung cancer. Histological types of lung cancer were squamous cell carcinoma in 12, adenocarcinoma in 9, and small cell carcinoma in 4, and as to the disease stage, stages III to IV were predominant. Analysis on relationship of chest X-ray findings between lung cancer and pulmonary tuberculosis revealed that in general, the location of lung cancer and tuberculosis seemed to be independent. Tuberculosis in the sequential group was more extensive and severer than in the concurrent group. In the concurrent group, treatment for tuberculosis was successful except for one case, and coexisting tuberculosis did not seem to affect the course of lung cancer among this group. However, in the sequential group, 5 patients died within 3 months, 2 of them died of tuberculosis. We consider that in the management of lung cancer, physicians should consider the possibility of coexistent active pulmonary tuberculosis and should not make delay in the diagnosis of active pulmonary tuberculosis.View full abstractDownload PDF (3006K) -
Fuminobu KURODA, Takenori YAGI, Fumio YAMAGISHI, Fumio MIZUTANI, Yuka ...1999 Volume 74 Issue 11 Pages 803-807
Published: November 15, 1999
Released on J-STAGE: May 24, 2011
JOURNAL FREE ACCESSWe report a case of pulmonary tuberculosis with acute renal failure caused by readministration of Rifampicin (RFP). A 73 year-old man was admitted to a certain hospital complaining with dyspnea on exertion. As his sputum smear was positive for acid-fast bacilli, he was transferred to our hospital for the isolation and treatment. He was diagnosed as lung tuberculosis and was administrated RFP, Isoniazid (INH) and Ethambutol (EB). On the 20th day after the initiation of treatment, the administration of drugs were suspended, because of liver dysfunction. After recovery of liver dysfunction, we have readministered antituberculous drugs, starting with EB, then INH, and finally RFP. On the 22th day after the readministration of RFP, acute renal failure was observed. All medications were suspended and we started treatment with hydration and furosemide. His renal function recovered after 7 weeks. Histopathological examination of the kidney revealed interstitial infiltration and tubular nephritis. According to the histopathological examination and the clinical course, we concluded acute renal failure was induced by the readministration of RFP. This case suggests that we have to pay attention to renal side effect of RFP in the course of readministration.View full abstractDownload PDF (4140K) -
1999 Volume 74 Issue 11 Pages 809-832
Published: November 15, 1999
Released on J-STAGE: May 24, 2011
JOURNAL FREE ACCESSDownload PDF (2979K)
- |<
- <
- 1
- >
- >|